The effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute stroke: a phase II double-blind randomised placebo-controlled trial
ISRCTN | ISRCTN98608690 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN98608690 |
Secondary identifying numbers | N/A |
- Submission date
- 15/02/2002
- Registration date
- 15/02/2002
- Last edited
- 06/09/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Diederik WJ Dippel
Scientific
Scientific
Dept of Neurology
University Hospital Rotterdam
PO Box 2040
Rotterdam
3000 CR
Netherlands
Phone | +31 (0)10 4639222 |
---|---|
dippel@neuro.fgg.eur.nl |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | |
Study acronym | PISA |
Study objectives | To study the effect of high-dose ibuprofen and to confirm the previously observed reducing effect of high-dose paracetamol on body temperature, and to study their safety in normothermic and subfebrile patients with acute ischaemic stroke. |
Ethics approval(s) | The medical ethics committees of the three hospitals have approved this protocol. |
Health condition(s) or problem(s) studied | Stroke |
Intervention | 1. Paracetamol 6 g daily, for 5 days 2. Ibuprofen 2.4 g daily, for 5 days 3. Placebo for 5 days |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Phase II |
Drug / device / biological / vaccine name(s) | Paracetamol (acetaminophen), ibuprofen |
Primary outcome measure | Body temperature at 24 hours from start of treatment. |
Secondary outcome measures | 1. Change in baseline temperature at 1 and 5 days from start of treatment 2. Time with elevated body temperature (greater than 37.0°C) (area under the curve) during the first 24 hours and the first five days Tertiary outcomes: Functional outcome at one month, as determined by the scores on the modified Rankin Scale (mRS) and Barthel Index (BI). |
Overall study start date | 01/12/2000 |
Completion date | 31/12/2001 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 75 |
Key inclusion criteria | 1. An acute ischaemic anterior circulation stroke 2. A body temperature greater than 36.0°C or less than 39.0°C 3. A CT scan that is compatible with acute ischaemic stroke 4. A focal deficit without rapid improvement 5. A possibility to start treatment within 24 hours after stroke onset |
Key exclusion criteria | 1. Severe aphasia, defined as an aphasia score of 2 or 3 on the National Institutes of Health Stroke Scale (NIHSS) 2. Treatment with an non-Steroidal Anti-Inflammatory Drug (NSAID) deemed necessary 3. Hypersensitivity to ibuprofen or paracetamol 4. (Chronic) liver failure or cirrhosis 5. (Chronic) renal failure 6. History of alcohol abuse 7. Active gastric ulcer disease or a history of peptic ulceration or gastro-intestinal haemorrhage in the preceding year 8. Colitis ulcerosa 9. Pregnancy 10. Use of corticosteroids 11. A severe concomitant medical condition that could affect the assessment of the effect of the study medication on temperature 12. Residual neurological impairment resulting from a previous stroke that may hamper the assessment of functional outcome 13. Death appearing imminent 14. No informed consent given |
Date of first enrolment | 01/12/2000 |
Date of final enrolment | 31/12/2001 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Dept of Neurology
Rotterdam
3000 CR
Netherlands
3000 CR
Netherlands
Sponsor information
Erasmus Medical Center (The Netherlands)
Hospital/treatment centre
Hospital/treatment centre
P.O. Box 1738
Rotterdam
3000 DR
Netherlands
Website | http://www.erasmusmc.nl/content/englishindex.htm |
---|---|
https://ror.org/018906e22 |
Funders
Funder type
Research organisation
Rotterdam Neurovascular Research Foundation (Stichting Neurovasculair Onderzoek Rotterdam) (The Netherlands)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | Protocol | 27/03/2002 | Yes | No | |
Results article | Results | 06/02/2003 | Yes | No |